BIOMARKERS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Biomarkers Market -Overview Global Biomarkers Market, by Product Type (Biomarker Test Kits and Biomarker Analyzers), by Disease Indication (Cancer, Cardiovascular Disorder, Infectious Disease, Neurological Disorder, Immunological Disorder, and Others), by Application (Diagnosis, Drug Discovery and Development, and Others), by End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, and Diagnostic Laboratories) is estimated to be valued at US$ 29,518.2 million in 2017 and is expected to exhibit a CAGR of 13.6% over the forecast period (20172025). The increasing product launches by market players, and rising number of government immunization programs are the major factors that are expected to drive growth of the global biomarkers market over the forecast period. Moreover, biomarker tests are mainly performed for diagnosis and drug discovery & development. It offers quick and accurate results, which has driven demand for biomarkers. Thus, it has lead manufacturers to focus on product launches, in order to cater to growing demand. For instance, GeneNEWS Limited launched BreastSentry, a new risk stratification test for breast cancer, in March 2017. BreastSentry integrates a blood-based biomarker test to determine a woman’s five year and lifetime risk for developing breast cancer. Similarly, in February 2018, Genomic Health, Inc. commercially launched Oncotype DX AR-V7 Nuclus Detect test in the U.S. Browse Research Report: https://www.coherentmarketinsights.com/marketinsight/biomarkers-market-1530 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Browse 45 Market Data Tables and 37 Figures spread through 187 Pages and in-depth TOC on " Biomarkers Market, by Product Type (Biomarker Test Kits and Biomarker Analyzers), by Disease Indication (Cancer, Cardiovascular Disorder, Infectious Disease, Neurological Disorder, Immunological Disorder, and Others), by Application (Diagnosis, Drug Discovery and Development, and Others ), by End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, and Diagnostic Laboratories) - Global Forecast to 2025“ * The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology. Request a Sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1530 FDA Biomarker Qualification Program was established in 2009 to support the Center for Drug Evaluation and Research’s (CDER's) work with external stakeholders to develop biomarkers that aids in drug development process. Biomarkers are majorly utilized in drug development process to improve the success rate and cost effectiveness. Thus, pharmaceutical companies are increasingly outsourcing complex bio analysis to cut down on costs, as well as to benefit from specialized expertise from the outsourced companies. This in turn, is expected to enhance efficiency of the drug development process. For instance, in March 2018, SenzaGen entered into a license agreement with Burleson Research Technologies, Inc., (BRT), a contract research organization in the U.S. that specializes in immunotoxicology. © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION •The global biomarkers market is expected to exhibit a CAGR of 13.6% over the forecast period (2017-2025), attributed to increasing diagnostic applications of biomarker and initiative for precision medicine, which are expected to drive the biomarkers market •Among product type, biomarker test kits segment is expected to holds a major market share over the forecast period, owing to increasing awareness about disease prevention and disease diagnosis tests among populace and healthcare providers •Among disease indication, cancer segment is expected to hold largest market share, in terms of revenue, attributed to increasing prevalence of cancer. For instance, according to the National Cancer Institute, 2016, around 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people suffering from cancer is expected to reach 19 million by 2024. •Key players operating in the global biomarkers market include Abbott Laboratories, Medtronic, BG Medicine, Inc., F. Hoffman LA Roche Ltd., Seimens Healthnineers, Nexus-DX, Qiagen N.V., and Lifesign LLC. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1530 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved